Valerie Darling Email and Phone Number
National Board of Directors, Nominating and Governance Committee, CEO Selection and Succession Committee at
@
Private Directors Association®
Atlanta, GA, US
Valerie Darling's Location
Atlanta Metropolitan Area, United States, United States
Valerie Darling's Contact Details
Valerie Darling work email
- Valid
- Valid
Valerie Darling personal email
n/a
Valerie Darling phone numbers
About Valerie Darling
Independent Board Director, multilingual global healthcare/biotechnology C-suite executive and strategic thinker adept at producing step changes in EBITDA, revenue growth, shareholder value, and successful exits/acquisitions for Fortune 100 and early-stage companies by building high-performing teams and innovative strategies. Fortune-trained executive, step change in the EBITDA CAGR in every assignment. Transformational leader in public and private companies in a highly regulated industry. Oversight experience in cybersecurity and AI. Experience in organizational change, M&A, integrations, startups, RIFs, VC and Private Equity-backed companies. Strategic entrepreneur and subject matter expert known for exceeding KPIs: revenue growth, profit margin, market share, product interaction, cost reduction, diverse talent development, retention, compliance, risk mitigation, technology, AI. International experience in oncology, genomic molecular diagnostics, cell and gene therapy, proteomics, specialty disorders, biotech, hospitals, medical devices. Bilingual Spanish, French, German. Hispanic, Latina, LatinX, diverse cultures, DEI. Member of Board of Directors, Advisory Boards. Excels in remote work environments: extensive global travel, worked remotely throughout career. Open to Board of Director opportunities. Engaging CEO, CBO, and CCO skilled at building, leading, and scaling high-performance global teams, strategic partnerships, and diverse cultures in high-growth and underperforming companies. My passion for diversity, training, and talent development consistently resulted in teams that exceeded and sustained corporate revenue and growth objectives. I place high focus on building relationships, strategic alliances and partnerships, networking, cross-functional collaboration with diverse business units. I create teamwork by breaking down barriers and driving actionable consensus toward common goals. My strategic planning, strong business acumen, "game-changing" entrepreneurial innovation, and C-suite contract negotiation have driven significant value for my companies in revenue, growth, product market share, and cost reduction. I have a passion for talent development and building winning teams!Oncology, Genomic / Molecular Diagnostics, Precision Medicine, Biotechnology, Specialty Disorders, Cell / Gene Therapy, Surgical, Medical Devices, Health IT, Digital Health, MedTech, Hospitals, medtech, Pharmaceuticals, Managed Care, Market Access, ACOs, GPOs, IDNs, MCOs, health systems, payers, providers, (678) 296-7287, gadarling@comcast.net
Valerie Darling's Current Company Details
Private Directors Association®
View
National Board of Directors, Nominating and Governance Committee, CEO Selection and Succession Committee
Atlanta, GA, US
- Website:
- privatedirectorsassociation.org
- Employees:
- 233
Valerie Darling Work Experience Details
-
National Board Of Directors, Nominating And Governance Committee, Ceo Selection And Succession CommitteePrivate Directors Association®Atlanta, Ga, Us
-
Board Of Directors, Independent DirectorSequentify 2022 - PresentRehovot, IlCancer and DNA genomic sequencing global company from Weizmann Institute of Science in Israel that provides market-fast, cost effective and flexible targeted panels for applications in oncology, carrier screening, COVID 19, and other diseases in 3 hours lab time. The company’s mission is to make targeted DNA sequencing as common, fast, and affordable as a blood test, enabling significant growth in personalized medicine. “Genomic diagnostics and therapeutics at a population-wide scale”. -
Member Board Of Directors, Nominating & Governance Committee, Ceo Selection Committee, Dei CommitteePrivate Directors Association® 2022 - PresentFrankfort, Il, UsThe Private Directors Association is the only national association dedicated exclusively to improving private companies' growth and sustainability through excellence in board formation and governance. Membership includes current and qualified future board members, private company owners, and C-level executives of family-owned businesses, ESOPs, venture capital-backed and private equity-owned, early-stage, and start-up organizations.Our mission is to create, sustain, and enhance Private Company value through the active use of Boards of Directors and Advisory Boards. We advocate for excellent practices in board formation and governance. We provide a national network where executives and professionals interested in board service can find and meet with those interested in securing exceptional board members.
-
Founder, Chair Of Membership And Engagement, National Dei CommitteePrivate Directors Association® 2019 - 2023Frankfort, Il, Us
-
Ceo And Chief Business OfficerLife Sciences Management Consultants 2018 - Present• Hired by two client companies as CCO/SVP of Commercial Operations and VP of Sales and Business Development after delivering successful outcomes through consulting (Cardinal Health, OpGen). Executed startups, M&A integration, restructuring of two companies, consultant 2013-2014.• Strategic Advisory Board member and consultant to VIC Technology Venture Development, Private Equity. License technologies/IP, fundraising, form startup companies, scale commercial growth, executive leadership• Strategic Advisor, consultant to RCE Technologies (AI Medtech, medical devices), Proteas Bioanalytics. Commercial strategy, capital raise• Advisor and consultant to COVID-19 diagnostic companies: Reliant Immune Diagnostics, MD Box, Anyplace-MD, BalinBac Therapeutics • Strategic Advisory Board Member, EnSignis Digital Technology • Advisor and Due Diligence Advisor (M & A) to venture capital and private equity companies including Commenda Capital, Asano Capital, Tings Capital. Seed-stage, early-stage life science/healthcare companies.• Managing Director/GM of company (VPs of Sales, Marketing, Operations, Business Development, Information Technology, Digital) for healthcare, medical, medtech, health IT, life sciences companies. Develop and execute commercial strategy, operational plans, due diligence, structuring, fundraising for startups. M & A, expansions, transitions, integrations, dissolutions. Early-stage, pre-IPO, late-stage companies • Biotech, medical devices, molecular diagnostics, genomic diagnostics, SaaS, digital health, AI Medtech, precision medicine, oncology, surgery / OR, hospitals / health systems, health IT / analytics, specialty therapeutics, cardiology, transplant, rare / orphan diseases, infectious disease• Catapulted $260M product launch for Cardinal Health; resulted in being hired as VP of Sales and Business Development• Drove $4M increase in lead product for a client, halting 5 successive years of revenue decline
-
Chief Business Officer And Chief Revenue OfficerProteas Bioanalytics Inc. 2023 - Sep 2024Execution of strategic partnerships, collaborations, and revenue streams. Board and executive roles ended due to dissolution of the board and restructuring of the company. Proteas Bioanalytics proteomic technology detects human diseases at their earliest stage, before the onset of symptoms, from a few drops of blood. Their advanced technologies provide objective guidance regarding treatment options and efficacy to dramatically reshape early diagnosis and treatment across multiple diseases.Proteas Bioanalytics has developed advanced analytical platforms that capture proteins in complex biological specimens such as primary cells, tissue biopsy or blood serum/plasma, that have predictive value for the early diagnosis, personalized treatment, and prognosis of disease.Diseases are predominately triggered, not by heredity (DNA or RNA), but by the effects of sustained environmental and lifestyle factors on thousands of individual proteins. Being able to observe and quantify these proteins in human blood and single cells derived from tissue biopsy, constitutes the most useful means to detecting active disease and response to treatments. The unprecedented performance of the Proteas proprietary technology is demonstrated by its ability to identify >5,000 distinct proteins with >99.9% analytical confidence, spanning a linear dynamic range of over 12-orders of magnitude, from a few drops of blood. -
Board Of Directors, Independent DirectorProteas Bioanalytics Inc. 2022 - Sep 2024Appointed Independent Board Director 2022, asked to join Executive Team by CEO in 2023; continued on Board of Directors. Board term ended due to dissolution of the board and restructuring of the company.
-
Member Of The Board Of AdvisorsNavvisa Jan 2022 - Apr 2023Sf Bay Area, UsCancer digital health company that partners with employee benefits programs, healthcare systems, and insurers to provide personalized cancer navigation services to anyone dealing with a cancer diagnosis-whether they are a patient, caregiver, or survivor-to help them better understand their diagnosis, evaluate treatment options, and plan the best path forward. -
Member Board Of DirectorsClass-Llc 2021 - 2023Atlanta, Georgia, UsCybersecurity Leadership and Strategy Solutions, LLC (CLASS-LLC) is a cybersecurity and AI Artificial Intelligence strategy, risk management, and workforce development professional services firm. CLASS-LLC develops security programs that help organizations manage AI and cybersecurity risk while achieving their business goals. Professional certification workshops and custom-developed training to develop the cybersecurity capabilities of the entire workforce. CLASS-LLC delivers world-class cybersecurity conferences and executive events that bring business, technology, and security leaders together to promote strategic thinking in cybersecurity. -
Member Of The Board Of AdvisorsVic Technology Venture Development™ 2020 - 2022Fayetteville, Ar, UsVIC Technology Venture Development (VIC TVD) identifies and licenses promising healthcare innovation from top research institutions across the world and forms new companies to commercialize the technologies. VIC’s technology venture development business model has been optimized to overcome limitations of traditional technology transfer approaches and usurp the large base of research conducted by U.S. universities and other research institutions. VIC drives strategic initiatives and activities within its portfolio companies to rapidly create value and greatly increase the probability of success. When considering whether to license a new technology, VIC’s internal Opportunity Assessment Team engages in an initial competitive landscape and intellectual property review, conducts a market analysis to evaluate market structure, size and growth prospects, identifies barriers to entry, and outlines a commercialization path. This type of careful consideration goes into all business development activities, at all stages of company development. In the early stages of a technology company’s development, full-time, executive level business management may not be practical or affordable. Instead, VIC recruits industry specific experts to work closely with its executive team in an advisory capacity and VIC provides its management services on an as-needed basis so human resources are used efficiently and cost-effectively. The cost of having a highly experienced team is spread across a number of companies ensuring that cash burn is minimized in all the companies. This model provides VIC’s startup portfolio companies exceptional management teams that would otherwise be unaffordable. As a given portfolio company matures, industry specific experienced permanent management is placed full-time into the given portfolio company. -
Member Of The Board Of AdvisorsEnsignis Digital 2019 - 2022Alpharetta, Georgia, UsGlobal IT company that delivers SaaS solutions for complex business problems with solutions-as-a-service model. The company focus is Digital Technologies, part of the EnSignis Company, and provides Advisory and Digital Transformation. -
Strategic Advisor - Rce TechnologiesRce 2019 - 2020Carlsbad, California, UsRCE Technologies is an AI med tech/medical device company that has developed an innovative ECG wearable and an optical based sensor device for non-invasive cardiac protein detection, which coupled with AI models can monitor levels of plaque in high-risk Coronary Artery Disease patients, particularly detecting silent heart attacks in the Diabetic population.RCE has product-complete, early clinical feasibility, pilots scheduled with prospective customers, and a strong team of PhDs, MDs, KOL clinicians, and board advisors working toward 510k submission and market development.• Winner of the 2019 Southeast Medical Device Association (SEMDA) Pitch Rounds competition • Selected as a Showcase Company for the Health Leaders Forum at the American Diabetes Association 11/1/19 in San Mateo, CA • Selected as a Featured Company by the New England Venture Summit 12/4/19 in Boston, MA• Selected as Featured Company in the Venture Atlanta Showcase 10/20 in Atlanta, GA -
Cco, Sr. Vice President Of Global Commercial Operations-Genomic Molecular Diagnostics, Precision MedOpgen, Inc. 2015 - 2017Rockville, Maryland, UsLeadership of the global commercial operations of OpGen, a genomic / molecular diagnostics and bioinformatics early commercial stage company and AdvanDx, (acquired by OpGen), both leaders in genomic diagnostics, precision medicine, NGS (sequencing.) Responsible for the integration of both companies, and building the commercial team. Directed all aspects of global commercialization including strategy and execution. Launch of Acuitas MDRO Gene test, Resistome, and the Acuitas Lighthouse Management System. OpGen has more than 10 years experience in human genome and microbial testing, and bioinformatics. Initially hired as consultant then hired as VP Commercial Operations. • Increased revenue 32% in first two quarters; halted 5 year revenue decline in acquired product• Drove 23% growth increase in target enterprise accounts: Cancer Centers of Excellence, hospitals/academic institutions, surgery centers, health systems/GPOs/IDNs, long-term care• Spearheaded culture integration and commercial operations of two companies with acquisition of AdvanDx Diagnostics • Reduced cost 19% by execution of restructuring and organic training: sales, marketing, advisory boards, KOLs • Drove sales of new HIMMS analytic solutions and management platform/system (SaaS/IT) and subscriptions to enterprise customers, large high-tech hospitals, health systems/IDNs, clinical trials. -
Member Board Of DirectorsFamily Lives On 2012 - 2016National foundation dedicated to serving bereaved children who have lost a parent by fulfilling traditions important to emotional and mental health and preserving memories of their lost parent, including the accompanying financial responsibility.
-
Vice President Of Sales & Business Development, Oncology | Immunology, Specialty Solutions (Startup)Cardinal Health 2009 - 2012Dublin, Oh, UsBuilt and led U.S. commercial strategy, business development, supply chain, distribution, sales and marketing teams of start-up oncology, immunology, SaaS, health IT, specialty therapeutics division for Fortune 17 multinational company, $121 billion revenue, 37,300 employees worldwide. Consultant, then hired to build a startup Oncology /Immunology division, 3 sales forces, 350 reports, reported to President. Included specialty solutions and integrated technology services SaaS / Health IT for patient and practice management, revenue management. Market Access, Supply Chain Management: GPOs, MCOs, IDNs, providers, payers. • Hired and led cross-functional teams for Sales, Operations, Market Access, Managed Care / MCO, Strategic Business Development, Medical Affairs, HR, Sourcing, Specialty Pharmacy and Training for major oncology and specialty multi-product launch in $78 billion market, B2B, buy and bill sector. • Built and led global start-up with $1.4B Profit & Loss responsibility.• Directed 3 sales teams: outside, inside and telesales (call center)-oncology, neurology, surgery, infectious disease, rheumatology. • $24M increase first year by development and execution of new contracts: GPOs, ACOs, IDNs, health systems, payers, providers, cancer centers, DoD, VA, managed care/MCOs.• Increased revenue 23% YOY second full year of operation.• Managed 22 Direct reports FTEs: VPs and Senior Directors of Market Access, Operations, Reimbursement, Critical Care, Acute Care, 6 Sales Directors, 6 National Account Directors, 2 Operations Directors, 6 GPO/IDN Directors, Sales Training Director, Business Analysts, Customer Success, outside sales force, inside sales force, telesales force. • Led efficiency change for Operational Excellence in Lean Six Sigma, high matrix environment.• Hired as consultant then as VP of Sales and Business Development.• Championed Unification Team to meld marketing and sales departments for positive culture change. -
Sr. East Regional Business Director, U.S. Biosurgery Division Zymogenetics (Startup)-Acquired By BmsBristol Myers Squibb 2007 - 2009Lawrence Township, Nj, UsRecruited to build a startup Biosurgery company from the ground floor up, 17 direct reports (surgical sales managers), grew to $27M in revenue. Executed operations of startup Surgery / OR division in new commercial venture. Hired sales force and directed marketing and product launch of recombinant thrombin and medical devices for surgical hemostasis. Trained surgeons in Operating Room in use of product and devices. Key opinion leader (KOL) development. Company acquired by Bristol Myers Squibb, product sold, commercial division dissolved.• Exceeded 100% sales and management objectives while executing pre-launch hiring and product launch of start-up biotech surgical / OR national sales force in first commercial venture of medical devices and recombinant thrombin: surgery, OR, oncology, hospital • Direct leadership of 17 Surgical Sales Managers (half of U.S. team)• Exceeded annual sales objectives 2007-2009 by 128%, 134%, and 138%; highest achievement in company• Sustained YOY revenue increases by developing and negotiating national account contracts to enterprise accounts: GPOs, IDNs, MCOs, DOD, surgery centers/OR/hospitals, health systems, cancer centers, payers, providers • Reduced external training costs by 48% by developing and executing training programs for surgeons, OR sales force, KOL development, Market Access, MCO /GPO reimbursement. • Call points: oncology, hematology, urology, orthopedic surgery, neurosurgery, vascular, hemophilia, pathology, hepatology, cardiovascular, transplant, thoracic, regenerative medicine, wound healing. -
U.S. Director Of Sales, Hospital, Surgical And Specialty DivisionEndo Pharmaceuticals 2005 - 2007Malvern, Pa, UsRecruited to turn around underperforming division. National leader of 180 member hospital surgical sales force, marketing, and home office personnel, 3.7B revenue, 6,400 employees. Directed U.S. operations of critical care hospital sales force and all U.S. management. Led sales, marketing, managed care and contracting efforts. Oversaw all national incentive compensation plans, personnel issues, and promotions. Hospital division dissolved 2007.• Achieved 45% increase in sales within one year; turned around an underperforming division into a profitable unit.• Catapulted 193% revenue increase in lead product by resolution of high impact shipping and storage issues• Doubled previous year revenue to $248M: Sales, Marketing, Managed Care, Contracts, PBMs, GPO, IDNs• Directed two new product launches and a major personnel expansion, enhancing product responsibility and credibility of the division. • 13 Direct Reports: Marketing Director, 10 Regional Sales Directors, 2 National Account Directors• Led transition during dissolution of hospital division due to non-renewed contract of in-licensed prime product from biopharma partnership. -
Senior Region Business Director, East Coast And Puerto Rico Genzyme (Startup)Sanofi Genzyme 1998 - 2005Paris, France, FrRecruited to build startup biotechnology company from ground floor, 27 direct reports-Clinical Science Managers, grew to $8.1B revenue, 10,100 employees. Recruited, hired, and promoted 27 diverse individuals in specialty/rare disease startup and Commercialization Launch. Executed sales, managed care, and contracting activities of Biotech Clinical Science Specialists on East Coast and Puerto Rico. Specialties: Renal, Metabolic, Hepatology, Lysosomal Storage Disorders, LSD, Orphan Drug, Rare Diseases.• Achieved 171% forecast/goal achievement in 1999, 168% forecast achievement in 2000-highest performing region in U.S.• Exceeded forecast all seven years; region achieved highest US market share and YOY growth increase all years of tenure• U.S. Circle of Excellence Winner 1999, 2000, and 2001 - #1 ranked region in forecast achievement in U.S.• Achieved highest market share in U.S. 1999-2003, RBD Market Share Award Winner 1999–2003• Appointed by President as Chairperson of Career Development, Succession Planning and Mentorship Program, 2000 - 2003• RBD Highest Business Gain/Conversion Award Winner, 2000 – 2004• Directed Global Sales Meeting Agenda and workshops 1999-2002. -
Senior Region Business Director, EastAstrazeneca 1996 - 1998Cambridge, Cambridgeshire, GbRecruited to turn around underperforming division of Fortune 25 global company, $22B revenue, 61,600 employees worldwide. Leadership of 150 reports, managers, trainers, sales representatives, market access managers in multiple specialty divisions. • Transformed lowest performing region to second highest region in first year (from 87% to goal, #15/15 to 145% forecast achievement, #2/15), to highest performing region in U.S. in second year (158%, #1/15)• Awarded President’s Circle Director Winner, 1997 (#1 ranked forecast achievement in U.S. of 950 Sales Personnel)• P & L responsibility of $448M revenue, launched multiple oncology, hospital, surgery, urology, cardiology products• Leadership of 150 FTEs, 15 Direct Reports: 13 Senior District Managers, National Accounts and Managed Care Managers, and Training Managers• 158% Forecast Achievement 1998), highest region in U.S.• 145% Forecast Achievement 1997, second highest in U.S.• Prioritized Talent Development - promoted 20% of region to positions of greater responsibility• Executed large scale expansion, doubled sales force•. Divisions: Oncology launch, Surgery, Urology, Cardiology, Market Access, Managed Care, Comprehensive Care. -
Senior Region Business Director Hospital And Specialty Sales Division (Startup)Johnson & Johnson 1990 - 1996New Brunswick, Nj, UsRecruited to build startup hospital division (medical device and therapeutics) for Fortune 15 multinational company, $76.5B revenue, 134,000 employees worldwide. 26 Direct reports: Surgical Managers, Hospital Sales Managers.Recruited, hired, and trained two diverse hospital sales forces for startup divisions (hospital and specialty pharmaceuticals) and oncology co-promotion. Drove revenue growth and sales results. Championed personnel development and promotions of two diverse sales forces in Eastern U.S. and Puerto Rico. • Developed contract responsible for $280 Million in U.S. quinolone sales in 2 years, and $1B brand within 4 years globally. Developed national hospital GPO/IDN contract. Resulted in 2,800 hospitals converting to product for exclusive use. Contract adopted by all GPOs, IDNs, DOD, VAs in U.S.• Awarded J & J Executive of the Year - overall corporate contribution• Exceeded corporate forecast YOY: 187%, 181%, 174% Forecast Achievement three consecutive years (1993 – 1995)• Won President’s Cup Award three consecutive years: 1993, 1994, and 1995 (#1 ranked region in U.S.)• Awarded Top Leader role by President: developed and led Management Training programs • Selected as Management Advisory Board Leader by peers• Achieved Stratosphere Award and International Trips 1993, 1994, 1995 (#1 ranked forecast achievement in U.S.)• Reduced training costs 90% by creating clinical/sales training programs• Manager of the Year Award Winner, 1993, (employee development, team results, coaching, corporate contribution)• Top Forecast Achievement Winner/ Partnership Japan Trip Award Winner, 1993• Executed LATAM, APAC, EMEA Launches with strategic partner companies' Board of Directors, Executive Teams • Opened market in Puerto Rico, responsible for product launches, market access/managed care, reimbursement• Sectors: oncology, surgery/OR, medical devices, transplant, vascular, neurology, nephrology, rheumatology, urology -
District Sales ManagerBristol Myers Squibb 1987 - 1990Lawrence Township, Nj, UsPromoted three times and to District Manager role. Led two sales teams (oncology and hospital/specialty sales) for Fortune 15 multinational company, $21B revenue, 24,000 employees worldwide. 22 direct reports• Doubled revenue in two years; achieved $148M in revenue • Achieved 157% forecast achievement in all products in 1987, 153% in 1988, 148% in 1989• Awarded Manager of the Year 1988 (#1 ranked forecast achievement in U.S./153%)• Winner of Great Performer Award 1988 (#1 ranked district in U.S.)• Awarded District Manager of the Region Award (#1 ranked district in Southeast Region)• Winner Anti-Infective Challenge Award 1989 (#1 ranked district in U.S.)• Directed sales personnel in specialty sectors: Oncology, Hospital, Academic Institutions, Surgery, Orthopedics, Urology, Nephrology, Rheumatology, Neurology, Pathology, Infectious Disease, Cardiology, Psychiatry• Executed managed care contracts to health systems, GPOs, IDNs, ACOs.
-
Corporate Sales TrainerBristol Myers Squibb Mar 1986 - Jan 1987Lawrence Township, Nj, UsPromoted to Corporate Sales Trainer.Developed and implemented corporate training for all Eastern, Southwest, and Midwest U.S. sales representatives. Ran HQ corporate Sales Training programs and field-based training. 95% travel.
-
Senior Oncology And Hospital Sales RepresentativeBristol Myers Squibb Jan 1984 - Mar 1986Lawrence Township, Nj, UsHospital, Oncology and Specialty Sales representative for multiple product line, Hispanic Territory (Little Havana) - All business conducted in Spanish. • Achieved 186% Forecast Achievement 1985, 168% Forecast Achievement 1986• Awarded Great Performers Award, Hospital/Specialty Sales Representative of the Year 1985, 1986 (#1 ranked in U.S.)• Region Representative of the Year Award Winner, 1985 (highest forecast achievement in SE Region)• Promoted to District Trainer 1985, 1986• 154%, 148% Forecast Achievement 1984, 1985 for total prime products
-
Founder / Vp Sales Diagnostics Biotech HealthcareDiagnostics Biotech Healthcare Sales Leaders In Atlanta 1983 - 1984
Valerie Darling Skills
Pharmaceutical Industry
Neurology
Oncology
Sales Operations
Medical Devices
Managed Care
Cross Functional Team Leadership
Strategic Planning
Pharmaceutical Sales
Start Ups
Healthcare
Sales Management
Urology
Cardiology
Biotechnology
Sales
Hospitals
Rheumatology
Product Development
Endocrinology
Key Account Management
Market Access
Hematology
Healthcare Information Technology
Dermatology
Diabetes
Strategic Leadership
Federal Government Sales
Infectious Diseases
National Accounts
Nephrology
Genetic Diagnostics
Diagnostics
Specialty Pharmacy
Channel Management
Sales Force Effectiveness
Critical Care
Pharmaceuticals
Consultative Selling
Orthopedics
Psychiatry
Commercial Management
Gpo
Molecular Diagnostics
Pulmonology
Transplant
Product Launches
Contract Negotiations
Reimbursement
Partnering
Pullthrough
Valerie Darling Education Details
-
Santa Clara University Leavey School Of BusinessWomen’S Corporate Board Readiness Program -
Universidad Complutense De MadridSpanish
-
University At AlbanySpanish
Frequently Asked Questions about Valerie Darling
What company does Valerie Darling work for?
Valerie Darling works for Private Directors Association®
What is Valerie Darling's role at the current company?
Valerie Darling's current role is National Board of Directors, Nominating and Governance Committee, CEO Selection and Succession Committee.
What is Valerie Darling's email address?
Valerie Darling's email address is ga****@****ast.net
What is Valerie Darling's direct phone number?
Valerie Darling's direct phone number is +177064*****
What schools did Valerie Darling attend?
Valerie Darling attended Santa Clara University Leavey School Of Business, Universidad Complutense De Madrid, University At Albany.
What are some of Valerie Darling's interests?
Valerie Darling has interest in Reading, Sports, Health, Children, Electronics, Outdoors, Education, Environment, Science And Technology, Human Rights.
What skills is Valerie Darling known for?
Valerie Darling has skills like Pharmaceutical Industry, Neurology, Oncology, Sales Operations, Medical Devices, Managed Care, Cross Functional Team Leadership, Strategic Planning, Pharmaceutical Sales, Start Ups, Healthcare, Sales Management.
Who are Valerie Darling's colleagues?
Valerie Darling's colleagues are Kathryn Loo, Kerim O., Boitumelo Rachel, Cordearo Dadson, Flossie O'leary, Katerina Vetsikas, Maria Piazza.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial